CVS Health Changes Leadership in Healthcare Delivery Businesses

CVS Health has made changes to its healthcare delivery leadership, with Jon Thiboutot named president of retail health and Marcus Lanznar taking over as president of CVS-owned home health firm Signify Health. Paymon Farazi, previously president of Signify, is leaving the company later this month. The changes come as CVS operates a range of healthcare businesses, including insurer Aetna, pharmacy benefit manager Caremark, and a chain of retail pharmacies.

CVS Health has announced significant leadership changes within its healthcare delivery businesses. Jon Thiboutot, a veteran of the company with over two decades of service, has been appointed as the new president of retail health. Thiboutot previously served as the vice president of operations for MinuteClinic, a subsidiary of CVS. Additionally, Marcus Lanznar has taken over as the president of CVS-owned home health firm Signify Health, replacing Paymon Farazi, who will be leaving the company later this month CVS changes healthcare delivery leadership^[1].

These changes come as CVS operates a diverse range of healthcare businesses, including insurer Aetna, pharmacy benefit manager Caremark, and a chain of retail pharmacies. The appointment of Thiboutot follows Dr. Creagh Milford's recent move to lead Oak Street Health, a chain of value-based medical clinics for seniors that CVS acquired in 2023 CVS changes healthcare delivery leadership^[1].

The leadership changes coincide with a period of operational challenges for CVS. The company's insurance arm, Aetna, faced elevated post-pandemic utilization trends and unfavorable 2024 Medicare Advantage star ratings last year. However, CVS has been making efforts to stabilize the business through strong execution, leadership changes, and operational enhancements. Aetna introduced a program to bundle approvals for certain cancer-related scans and tests, reducing administrative burdens for providers and expediting treatment. Additionally, the company has partnered with hospitals to support members as they change care settings, reducing readmissions and improving outcomes CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?^[2].

Despite these challenges, CVS Health's stock performance has been robust. Year-to-date, CVS shares have surged 64.8% against the industry's 2.1% fall. The company's forward five-year earnings multiple of 10.72 is lower than the industry average of 15.03, indicating a potentially undervalued stock. However, the company's Zacks Rank of #3 (Hold) suggests a cautious outlook CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?^[2].

In comparison, UnitedHealth Group, another major healthcare provider, also faced significant challenges in 2025. UnitedHealth's share price has risen 35% since its low point in May, but the company's stock remains heavily discounted from its former highs CVS Health Vs. UnitedHealth: Companies In Crises - Back United's Recovery^[3]. Both CVS and UnitedHealth are attempting to introduce a "value-based care" approach to healthcare, rewarding physicians based on patient outcomes rather than fee-for-service CVS Health Vs. UnitedHealth: Companies In Crises - Back United's Recovery^[3].